Presentation TCT 2016 Hot Topic #2: Lipid Lowering Targets and the Potential Role of the PSCK9 Inhibitors in Routine Clinical Practice Presenter: Bernard J. Gersh, Felix Mahfoud, Evan A. Stein November 01, 2016
Presentation TCT 2016 Hot Topic #1: Implications of the SPRINT Trial on the Target for Blood Pressure Control Presenter: Bernard J. Gersh, Felix Mahfoud November 01, 2016
Presentation TCT 2016 TCT 387: Sirolimus-Coated Balloons for the Prevention of Vascular Restenosis in Small Vessel Disease: Insights From the Nanoluté Registry Presenter: Germano Di Sciascio, Bruno Scheller November 01, 2016
Presentation TCT 2016 Twelve-Month Safety and Efficacy of CGuard Micro-Net-Covered Embolic Prevention System: Routine Use to Perform Carotid Revascularization in Symptomatic and Increased Stroke Risk Asymptomatic Patients: The PARADIGM All-Comer Prospective Study Presenter: Robert M. Bersin, John R. Laird Jr., Piotr Musialek November 01, 2016
Presentation TCT 2016 Update on Radial Artery Occlusion: Incidence, Presentation, Prevention, and Treatment Presenter: Francesco Burzotta, Sunil V. Rao, Samir B. Pancholy October 30, 2016
News Conference News TCT 2016 YELLOW II: Improved Cholesterol Efflux Linked to Plaque Stabilization in Statin-Treated Patients Michael O'Riordan October 29, 2016
News Opinion Editor's Corner TCT 2016 TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever Shelley Wood October 24, 2016
Presentation TCT 2015 Neurological Complications of TEVAR: Prevention and Management Presenter: Wilson Y. Szeto, Rodney White, Michael D. Dake October 15, 2015
Presentation TCT 2015 Debate: Are We Really Ready for Phase III Trials? Yes, Mesenchymal Cells Are Ready to Be Tested for Prevention and Treatment of Chronic Ischemic and Nonischemic Heart Failure! Presenter: Francisco Fdez-Aviles, Timothy D. Henry, Emerson C. Perin October 15, 2015
Presentation TCT 2015 Vorapaxar: Lessons From the Randomized Trials in ACS and for Secondary Prevention Presenter: Eric R. Bates, Neal S. Kleiman, Ori Ben-Yehuda October 15, 2015
Presentation TCT 2015 Convince Me in 5 Minutes or Less That: Intravenous and Not Oral Hydration Is the Cornerstone for Contrast Nephropathy Prevention! Presenter: Somjot S. Brar, Richard Solomon October 15, 2015
Presentation TCT 2015 The Critical Role of Lesion Preparation for BRS: Effects of Plaque Morphology, Components, and Novel Devices Presenter: Detlef G. Mathey, Nicolas M. Van Mieghem, Giulio Guagliumi October 14, 2015
Presentation TCT 2015 Scaffold Expansion as the Essential Requirement to Prevent BRS Failure Presenter: Detlef G. Mathey, Nicolas M. Van Mieghem, Stephan Achenbach October 14, 2015
Presentation TCT 2015 Tips and Tricks to Optimize Acute and Long-term BRS Outcomes Presenter: Detlef G. Mathey, Nicolas M. Van Mieghem, Antonio Colombo October 14, 2015
Presentation TCT 2015 Imaging Insights Into BRS Failure Modes (Thrombosis and Restenosis) Presenter: Detlef G. Mathey, Nicolas M. Van Mieghem, Yoshinobu Onuma October 14, 2015
Presentation TCT 2015 Neoatherosclerosis After BRS May Occur Presenter: Detlef G. Mathey, Nicolas M. Van Mieghem, Corrado Tamburino October 14, 2015
Presentation TCT 2015 Incidence and Predictors of BRS Scaffold Thrombosis Presenter: Detlef G. Mathey, Nicolas M. Van Mieghem, Luis Ortega Paz, MD October 14, 2015
Presentation TCT 2015 What Are the Hard Data Regarding the Impact of Medical Therapy on Stroke Prevention in Established Severe Carotid Stenosis? Presenter: William A. Gray, D. Christopher Metzger, Klaus D. Mathias October 14, 2015
News Conference News TCT 2015 CREST-2 Triggers Spirited Debate on Merits of CAS vs. CEA Todd Neale October 14, 2015
Presentation TCT 2015 TCT 73: Impact of Routine MicroNet-Covered Embolic Prevention Stent System Use on Contemporary Carotid Revascularization All-Comer PARADIGM Study Presenter: Mark C. Bates, Mark H. Wholey, Piotr Musialek October 13, 2015